These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 30232464)

  • 21. [Not Available].
    Mosca M; Vertenoeil G; Toppaldoddi KR; Plo I; Vainchenker W
    Bull Cancer; 2016 Jun; 103(6 Suppl 1):S16-28. PubMed ID: 27494969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CAL2 Immunohistochemical Staining Accurately Identifies CALR Mutations in Myeloproliferative Neoplasms.
    Nomani L; Bodo J; Zhao X; Durkin L; Loghavi S; Hsi ED
    Am J Clin Pathol; 2016 Oct; 146(4):431-8. PubMed ID: 27686170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Author Correction: Synthetic RNA-based logic computation in mammalian cells.
    Matsuura S; Ono H; Kawasaki S; Kuang Y; Fujita Y; Saito H
    Nat Commun; 2019 Apr; 10(1):1950. PubMed ID: 31028267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pegylated interferon alpha - 2a is clinically effective and tolerable in myeloproliferative neoplasm patients treated off clinical trial.
    Gowin K; Jain T; Kosiorek H; Tibes R; Camoriano J; Palmer J; Mesa R
    Leuk Res; 2017 Mar; 54():73-77. PubMed ID: 28113109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. JAK and MPL mutations in myeloid malignancies.
    Tefferi A
    Leuk Lymphoma; 2008 Mar; 49(3):388-97. PubMed ID: 18297515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukemia with megakaryocytic differentiation following essential thrombocythemia and myelofibrosis. Case report and review of the literature.
    Patiño-Sarcinelli F; Knecht H; Pechet L; Pihan G; Savas L; Snyder LM
    Acta Haematol; 1996; 95(2):122-8. PubMed ID: 8638441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in the molecular characterization of Philadelphia-negative chronic myeloproliferative disorders.
    Pikman Y; Levine RL
    Curr Opin Oncol; 2007 Nov; 19(6):628-34. PubMed ID: 17906464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Publisher Correction: EMT cells increase breast cancer metastasis via paracrine GLI activation in neighbouring tumour cells.
    Neelakantan D; Zhou H; Oliphant MUJ; Zhang X; Simon LM; Henke DM; Shaw CA; Wu MF; Hilsenbeck SG; White LD; Lewis MT; Ford HL
    Nat Commun; 2018 Nov; 9(1):4720. PubMed ID: 30420638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic lymphocytic leukemia and myeloproliferative neoplasms concurrently diagnosed: clinical and biological characteristics.
    Todisco G; Manshouri T; Verstovsek S; Masarova L; Pierce SA; Keating MJ; Estrov Z
    Leuk Lymphoma; 2016 May; 57(5):1054-9. PubMed ID: 26402369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New mutations of MPL in primitive myelofibrosis: only the MPL W515 mutations promote a G1/S-phase transition.
    Chaligné R; Tonetti C; Besancenot R; Roy L; Marty C; Mossuz P; Kiladjian JJ; Socié G; Bordessoule D; Le Bousse-Kerdilès MC; Vainchenker W; Giraudier S
    Leukemia; 2008 Aug; 22(8):1557-66. PubMed ID: 18528423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of poly(ADP-ribose) polymerase 1 protects against acute myeloid leukemia by suppressing the myeloproliferative leukemia virus oncogene.
    Wang L; Cai W; Zhang W; Chen X; Dong W; Tang D; Zhang Y; Ji C; Zhang M
    Oncotarget; 2015 Sep; 6(29):27490-504. PubMed ID: 26314963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myeloproliferative neoplasms: A decade of discoveries and treatment advances.
    Tefferi A
    Am J Hematol; 2016 Jan; 91(1):50-8. PubMed ID: 26492355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myelofibrosis revisited: characterization and classification of myelofibrosis in the setting of myeloproliferative disease.
    Gilbert HS
    Prog Clin Biol Res; 1984; 154():3-17. PubMed ID: 6382299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [18F-FDG-PET/CT is effective in distinguishing myelofibrosis due to bone marrow infiltration of diffuse large B-cell lymphoma from triple-negative primary myelofibrosis].
    Kumagai T; Satoh Y; Koshiishi M; Ooishi S; Sueki Y; Nakajima K; Mitsumori T; Kirito K
    Rinsho Ketsueki; 2017; 58(3):228-232. PubMed ID: 28381690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular genetic evaluation of myeloproliferative neoplasms.
    Azzato EM; Bagg A
    Int J Lab Hematol; 2015 May; 37 Suppl 1():61-71. PubMed ID: 25976962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TGF-beta and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders.
    Martyré MC
    Leuk Lymphoma; 1995 Dec; 20(1-2):39-44. PubMed ID: 8750621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correction to: Liver Safety of Fasiglifam (TAK-875) in Patients with Type 2 Diabetes: Review of the Global Clinical Trial Experience.
    Marcinak JF; Munsaka MS; Watkins PB; Ohira T; Smith N
    Drug Saf; 2018 Dec; 41(12):1431-1437. PubMed ID: 30328587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. JAK2 and MPL gene mutations in V617F-negative myeloproliferative neoplasms.
    Siemiatkowska A; Bieniaszewska M; Hellmann A; Limon J
    Leuk Res; 2010 Mar; 34(3):387-9. PubMed ID: 19643476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of pegylated-interferon α-2a in myelofibrosis: a study by the FIM and GEM French cooperative groups.
    Ianotto JC; Boyer-Perrard F; Gyan E; Laribi K; Cony-Makhoul P; Demory JL; De Renzis B; Dosquet C; Rey J; Roy L; Dupriez B; Knoops L; Legros L; Malou M; Hutin P; Ranta D; Schoenwald M; Andreoli A; Abgrall JF; Kiladjian JJ
    Br J Haematol; 2013 Sep; 162(6):783-91. PubMed ID: 23848933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phospho-STAT5 expression pattern with the MPL W515L mutation is similar to that seen in chronic myeloproliferative disorders with JAK2 V617F.
    Gibson SE; Schade AE; Szpurka H; Bak B; Maciejewski JP; Hsi ED
    Hum Pathol; 2008 Jul; 39(7):1111-4. PubMed ID: 18479730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.